Skip to content

Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women

Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01919476
Enrollment
18
Registered
2013-08-09
Start date
2011-09-30
Completion date
2016-03-31
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Gestational

Keywords

Postprandial, Insulin resistance, Lipids, Satiety, Almonds

Brief summary

Currently, about one third of all women entering pregnancy are obese. The prevalence of metabolic disorders during pregnancy has increased concurrently with the rise in maternal obesity. Although dietary interventions are used routinely to reduce metabolic disease in non-pregnant obese individuals, no specific dietary advice is provided to obese, pregnant women unless they develop gestational diabetes mellitus. In this study, the investigators will specifically assess the effect of replacing dairy fats with almonds in a breakfast meal on the postprandial metabolic response. This cross-over, randomized control trial will examine the postprandial metabolic response to 0 or 2 oz of almonds in standardized test meals in pregnant Hispanic women with prepregnancy BMI between 25 and 40. Hispanics are at higher risk for gestational diabetes and the metabolic syndrome. The investigators hypothesize that consuming almonds in place of dairy fat reduces the glycemic response and improves the postprandial lipid profile in these high-risk women.

Interventions

OTHERBagel
OTHERCream Cheese

Sponsors

UCSF Benioff Children's Hospital Oakland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant Hispanic women * Between 30 and 36 weeks gestation * Prepregnancy BMI between 25 and 40

Exclusion criteria

* Diagnosis of gestational diabetes mellitus * Preexisting diabetes mellitus * Renal disease * Thyroid disease * Cardiovascular disease * History of drug abuse * Nut allergies

Design outcomes

Primary

MeasureTime frameDescription
Change in markers for glucose intolerance.0, .5, 1, 2, 3, 4, 5 hours following a mealAfter consuming the breakfast meal markers for glucose intolerance will be measured at the time points listed

Secondary

MeasureTime frameDescription
Change in metabolic markers0, .5, 1, 2, 3, 4, 5 hours following a mealAfter consuming the breakfast meal metabolic markers will be measured at the time points listed.

Other

MeasureTime frameDescription
Change in satiety markers0, .5, 1, 2, 3, 4, 5 hours following a mealAfter consuming the breakfast meal satiety markers will be measured at the time points listed. Satiety questionnaires will also be given at the listed time points and food intake from a buffet will be measured.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026